APA (7th ed.) Citation

Burhenne, J., Halama, B., Maurer, M., Riedel, K., Hohmann, N., Mikus, G., & Haefeli, W. E. (2012). Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1′-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry. Analytical and bioanalytical chemistry, 402(7), . https://doi.org/10.1007/s00216-011-5675-y

Chicago Style (17th ed.) Citation

Burhenne, Jürgen, Birte Halama, Monika Maurer, Klaus-Dieter Riedel, Nicolas Hohmann, Gerd Mikus, and Walter E. Haefeli. "Quantification of Femtomolar Concentrations of the CYP3A Substrate Midazolam and Its Main Metabolite 1′-hydroxymidazolam in Human Plasma Using Ultra Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry." Analytical and Bioanalytical Chemistry 402, no. 7 (2012). https://doi.org/10.1007/s00216-011-5675-y.

MLA (9th ed.) Citation

Burhenne, Jürgen, et al. "Quantification of Femtomolar Concentrations of the CYP3A Substrate Midazolam and Its Main Metabolite 1′-hydroxymidazolam in Human Plasma Using Ultra Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry." Analytical and Bioanalytical Chemistry, vol. 402, no. 7, 2012, https://doi.org/10.1007/s00216-011-5675-y.